Effect of exercise training on autonomic derangement and neurohumoral activation in chronic heart failure

Maaike G J Gademan1, Cees A Swenne, Harriette F Verwey

  • 1Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

Insights

Exercise training improves autonomic function in chronic heart failure (CHF) by enhancing baroreflex sensitivity and reducing sympathetic nervous system activity. This approach offers a promising strategy for managing CHF patients.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Autonomic Neuroscience

Background:

  • Chronic heart failure (CHF) is characterized by autonomic dysfunction and neurohumoral imbalance, leading to organ damage and reduced quality of life.
  • Pharmacotherapy offers benefits but cannot fully normalize autonomic derangement in CHF.
  • Exercise training is increasingly recognized for its potential to mitigate these detrimental effects.

Purpose of the Study:

  • To evaluate the impact of exercise training on autonomic derangement and neurohumoral activation in patients with chronic heart failure.
  • To synthesize existing evidence on the mechanisms through which exercise training influences the autonomic nervous system in CHF.

Main Methods:

  • Systematic review and analysis of available evidence on exercise training in CHF.
  • Assessment of changes in baroreflex sensitivity, heart rate variability, and sympathetic outflow.
  • Evaluation of alterations in plasma levels of key neurohormones.

Main Results:

  • Exercise training was found to increase baroreflex sensitivity and heart rate variability.
  • Significant reductions were observed in sympathetic outflow and plasma levels of catecholamines, angiotensin II, vasopressin, and brain natriuretic peptides at rest.
  • These findings indicate a sympathoinhibitory effect of exercise training in CHF.

Conclusions:

  • Exercise training exerts direct and reflex sympathoinhibitory effects, offering significant benefits in CHF management.
  • Further research is needed to fully elucidate the mechanisms underlying exercise-induced autonomic normalization.
  • Optimizing CHF-related training programs requires a deeper understanding of these mechanisms to maximize efficacy and minimize patient workload.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...